Blogs
Sources de cette bibliothèque
Documents les plus récents
-
STADA and SBP Group Launch Biosimilars Partnership
STADA and Sino Biopharmaceutical Limited (“SBP Group”), through its subsidiary Chia Tai Tianqing Pharmaceutical Group (“CTTQ”), have entered into a partnership to manufacture, market, and sell biosimilars. CTTQ will develop, manufacture, and supply biosimilar candidates, while STADA will hold the marketing authorizations and have exclusive sales and marketing rights in the European Union, Switzerland, the...
-
Swiss scientists reveal Listeria trends
An analysis of Listeria in Switzerland covering six years has revealed several outbreaks and sporadic cases connected to international incidents. Researchers collected 335 Listeria monocytogenes isolates from cases of listeriosis occurring in Switzerland between 2019 and 2024. They have recently published the results and said they show the importance of implementing whole genome sequencing for routine Listeria monocytogenes...
- Who Is Liable When The Car Steers Itself?
- Your Supplier Is Using AI. Is It In Your Contract?
- Switzerland's New Transparency Register – What Companies And Their Stakeholders Need To Know Now
- New Act On The Transparency Of Legal Persons (TLPA): Entry Into Force On 1 October 2026
- Get Ready For The EU AI Act Transparency Obligations For AI Systems
- EU AI Act Transparency Obligations For AI Systems - What Swiss Providers And Deployers Need To Know From August 2026
- Tax Loss Carryforwards Under Swiss Tax Law: The Most Important Practical Pitfalls Despite The New 10-Year Carryforward Period
- Financial Restructuring: Mind The Tax Traps
